Funded Health Care Startups in Amsterdam
Disclosed funding levels in this Amsterdam health care slice are split between one high outlier and a cluster of mid-sized rounds: Funda (2021-02-24) raise…
Disclosed funding levels in this Amsterdam health care slice are split between one high outlier and a cluster of mid-sized rounds: Funda (2021-02-24) raised $15M, while the next-largest disclosed amounts are far lower ($12M for Castor on 2020-08-19; $6M for FunXtion on 2022-09-01). Several smaller rounds sit near the $320K–$410K range (Pal $320K on 2023-09-20; Speaklee $410K on 2025-08-12; Layco $330K on 2023-11-21), showing a wide spread rather than a tight band.
Temporally, the 10 most recent entries span 2020-07-07 (Synthesis) to 2025-08-12 (Speaklee), with a concentration in 2023: Yoni (2023-12-14, $3M), Layco (2023-11-21, $330K), Binqy (2023-09-26, undisclosed), and Pal (2023-09-20, $320K) all appear within about 3.5 months. Stage disclosure is also uneven: 2/10 entries are “Series Unknown” (Speaklee 2025-08-12, Yoni 2023-12-14) and 1/10 is explicitly “undisclosed” (Binqy 2023-09-26).
Most recent rounds
10 shownRelated listings
Frequently asked
What’s the largest disclosed round here, and is it close to the rest or a true outlier?
Funda’s $15M on 2021-02-24 is the largest disclosed amount and it materially dwarfs the next-largest disclosed rounds: Castor at $12M (2020-08-19) and FunXtion at $6M (2022-09-01). After those, the disclosed amounts fall to the ~$320K–$3M range (e.g., Pal $320K on 2023-09-20; Yoni $3M on 2023-12-14; Layco $330K on 2023-11-21).
Do the rounds cluster in a particular time window among these 10 most recent entries?
Yes, 2023 is visibly dense: Yoni (2023-12-14, $3M), Layco (2023-11-21, $330K), Binqy (2023-09-26, undisclosed), and Pal (2023-09-20, $320K) all fall within roughly 3.5 months. By contrast, the list also stretches to 2025-08-12 (Speaklee) and back to 2020-07-07 (Synthesis), indicating a long tail outside that 2023 cluster.
How much of the list has unclear or missing funding amounts (undisclosed vs. “Series Unknown”)?
Funding visibility is mixed: 1/10 is explicitly “undisclosed” for amount (Binqy on 2023-09-26), while 2/10 are labeled “Series Unknown” (Speaklee 2025-08-12 and Yoni 2023-12-14), each with a disclosed dollar amount ($410K and $3M, respectively). The remaining entries have specific stages shown (e.g., FunXtion’s Series A at $6M on 2022-09-01; Founda’s Seed at $15M on 2021-02-24).
Which stages dominate this Amsterdam health care set, based on what’s disclosed in the table?
No single stage dominates the full set: Pre-Seed appears in 3/10 entries (Platos 2025-05-07 $1M; Pal 2023-09-20 $320K; and 1 other Pre-Seed row listed in the table), while Seed appears in 3/10 entries (Layco $330K on 2023-11-21; Founda $15M on 2021-02-24; and Binqy is Seed but has undisclosed amount on 2023-09-26). Series A appears once (FunXtion $6M on 2022-09-01), and two rows are “Series Unknown” (Speaklee and Yoni).
Are there notable outliers to consider beyond the largest round amount itself?
Besides Funda’s $15M (2021-02-24), the other clear “positioning” outlier is the $1M Pre-Seed for Platos on 2025-05-07, which is close to the smallest disclosed amounts ($320K for Pal on 2023-09-20 and $330K for Layco on 2023-11-21) rather than to the mid-to-high cluster. Additionally, Binqy on 2023-09-26 is an outlier for reporting quality because the amount is “undisclosed,” preventing direct comparison to the disclosed ranges.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.